Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOLYSIN + Paclitaxel + Carboplatin in Metastatic Melanoma
NCT00984464Phase 2Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Sep 2009
- Primary completion
- Feb 2014
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pelareorep in melanoma, sponsored by Oncolytics Biotech Inc.. Started Sep 2009; status: completed.
02
Drugs
pelareorep
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00984464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984464.